Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

NCT05831969 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Advanced HCC

Interventions

DRUG: Lenalidomide

Sponsor

Shenyang Tenth People's Hospital

Collaborators

[object Object]